Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.46 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.46 |
| ▸ | LSS | P48449 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL5346402 | 0.98 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL5574352 | 0.98 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL15732741 | 0.98 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Formic Acid SCHEMBL5570521 | 0.98 | DNM1 (0.52) | DNM1HTTSLC22A1LSSKMT2A | |
| Tributylmethylammonium SCHEMBL557488 | 0.92 | SLC22A1 (0.41) | DNM1HTTSLC22A1SLC22A2 | |
| Formic Acid SCHEMBL5574434 | 0.85 | DNM1 (0.67) | DNM1HTTSLC22A1SLC22A2KMT2A | |
| Formic Acid SCHEMBL5574268 | 0.85 | LSS (0.48) | DNM1HTTSLC22A1SLC22A2LSS | |
| Tetrapentylammonium SCHEMBL2531235 | 0.84 | SLC22A1 (0.67) | DNM1SLC22A1SLC22A2 | |
| SCHEMBL2013654 | 0.84 | SLC22A1 (0.62) | DNM1HTTSLC22A1SLC22A2LSS | |
| SCHEMBL16150229 | 0.84 | SLC22A1 (0.62) | DNM1HTTSLC22A1SLC22A2LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9428438-B2 | Process for preparing formic acid | BASF SE (DE) | 2016-08-30 | — | — | US | disclosed |
| US-20140148617-A1 | PROCESS FOR PREPARING FORMIC ACID | BASF SE (DE) | 2014-05-29 | — | — | US | disclosed |
| US-20070135565-A1 | COMPOSITION FOR FORMING POROUS FILM, POROUS FILM AND METHOD FOR FORMING THE SAME, INTERLEVEL INSULATOR FILM, AND SEMICONDUCTOR DEVICE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2007-06-14 | — | — | US | disclosed |
| US-7132473-B2 | Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2006-11-07 | — | — | US | disclosed |
| EP-1568744-A1 | COMPOSITION FOR POROUS FILM FORMATION, POROUS FILM, PROCESS FOR PRODUCING THE SAME, INTERLAYER INSULATION FILM AND SEMICONDUCTOR DEVICE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2005-08-31 | — | — | EP | disclosed |
| US-20040219372-A1 | Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148617-A1 | PROCESS FOR PREPARING FORMIC ACID | MSMO1, FEN1, MED1 | DNM1 136/4885HTT 3346/4885SLC22A1 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.